EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study

Nicholas S Britt, Karim Khader iD, Tao He, Andrea M Prinzi iD, Benjamin Hommel, Tristan T Timbrook iD, Emily M Potter, Thomas P Lodise iD

Clinical Infectious Diseases · 07.10.2026 · 83 (3) · e461-e471

DOI: 10.1093/cid/ciag328 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 12.06.2026. Verfasst von Nicholas S Britt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, University of Kansas School of Pharmacy, Lawrence, Kansas, USA. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Pneumonia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rapid diagnostics such as the BIOFIRE® FILMARRAY® Pneumonia (PN) Panel may enhance antibiotic optimization, yet real-world evidence remains limited, and few studies have assessed how differences in institutional antimicrobial stewardship (ASP) capacity influence clinical outcomes.

Methods

We conducted a national, multicenter retrospective study of ICU patients with pneumonia admitted to Veterans Health Administration hospitals. Hospitals that implemented the PN Panel for ≥6 months served as intervention sites, while matched facilities without implementation served as controls. Outcomes were assessed using a difference-in-differences framework with inverse probability weighting to account for baseline imbalances and secular trends, including those related to the COVID-19 pandemic. Co-primary outcomes, assessed following index culture collection, were early antimicrobial de-escalation (24–48 hours) and early appropriate therapy (0–24 hours); secondary outcomes were 30-day and ICU mortality.

Results

The study included 11 746 patients, including 4523 from hospitals that implemented the BIOFIRE® PN Panel and 7223 from matched control hospitals. Overall, PN implementation was associated with early antimicrobial de-escalation (adjusted RR [aRR], 1.14; 95% CI, 1.04–1.26). Among culture-positive patients, PN Panel implementation was significantly associated with early antimicrobial de-escalation (aRR, 1.23; 95% CI, 1.02–1.50) and early appropriate therapy (aRR, 1.11; 95% CI, 1.04–1.18). Overall ICU and 30-day mortality did not differ, though ICU mortality among culture-positive patients was relatively lower following PN Panel implementation (aRR, .70; 95% CI, 0.50–0.97). Improvements in antimicrobial optimization were most evident in hospitals with greater ASP capacity.

Conclusions

BIOFIRE® PN Panel implementation improved antibiotic optimization in critically ill pneumonia patients, with the greatest gains seen in hospitals with comprehensive ASP programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial StewardshipPneumoniaAgedFemaleHumansMaleMiddle AgedAnti-Bacterial AgentsHospitals, VeteransIntensive Care UnitsRetrospective StudiesSARS-CoV-2United StatesUnited States Department of Veterans Affairs

Stichwörter der Autor:innen

BIOFIREVeterans Health Administrationpneumoniapneumonia panel antimicrobial stewardshiprapid diagnostic testing

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy Practice, University of Kansas School of Pharmacy, Lawrence, Kansas, USA.
  • Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, Kansas, USA.
  • Pharmacy Service, Dwight D. Eisenhower Veterans Affairs Medical Center, Leavenworth, Kansas, USA.
  • Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • IDEAS Center of Innovation, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA.
  • bioMérieux, Marcy L'etoile, France.

ORCID-Profile: Karim Khader, Andrea M Prinzi, Tristan T Timbrook, Thomas P Lodise

Zitieren

APA

Britt, N. S., Khader, K., He, T., Prinzi, A. M., Hommel, B., Timbrook, T. T., Potter, E. M., & Lodise, T. P. (2026). Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study. Clinical Infectious Diseases, 83(3), e461-e471. https://doi.org/10.1093/cid/ciag328

Vancouver

Britt NS, Khader K, He T, Prinzi AM, Hommel B, Timbrook TT, et al. Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study. Clinical Infectious Diseases. 2026;83(3):e461-e471. doi:10.1093/cid/ciag328

BibTeX
@article{Britt2026,
  author = {Britt, Nicholas S and Khader, Karim and He, Tao and Prinzi, Andrea M and Hommel, Benjamin and Timbrook, Tristan T and Potter, Emily M and Lodise, Thomas P},
  title = {Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {83},
  number = {3},
  pages = {e461--e471},
  doi = {10.1093/cid/ciag328}
}
Kostenlos starten →